Desoximetasone Production Cost Reports

The report provides a detailed analysis essential for establishing a desoximetasone production plant. It encompasses all critical aspects necessary for desoximetasone production, including the cost of desoximetasone production, desoximetasone plant cost, desoximetasone production costs, and the overall desoximetasone production plant cost. Additionally, the study covers specific expenditures associated with setting up and operating a desoximetasone production plant. These encompass production processes, raw material requirements, utility requirements, infrastructure needs, machinery and technology requirements, manpower requirements, packaging requirements, transportation requirements, and more.

Desoximetasone is a potent synthetic corticosteroid, mainly utilized in the pharmaceutical industry for topical formulations such as creams, ointments, gels, and sprays at concentrations of 0.05% to 0.25% to treat inflammatory skin conditions like psoriasis, eczema, and atopic dermatitis. It reduces redness, itching, and swelling through glucocorticoid receptor binding and immune suppression. It functions as an active pharmaceutical ingredient (API) requiring stringent handling protocols, including local exhaust ventilation, fume hoods, and dust control during processes like grinding or weighing to mitigate airborne exposure risks.

The market demand for desoximetasone is driven by its role as a high-potency topical corticosteroid for treating inflammatory dermatological conditions like psoriasis, eczema, and atopic dermatitis. The rising global prevalence of these disorders, exacerbated by ageing populations, urbanisation, and environmental factors, is fuelling demand in pharmaceutical formulations. The increasing R&D investments by pharma companies target advanced delivery systems, such as niosomal gels for better skin permeation and stability, along with regulatory support for generics and biosimilars that enhance affordability and market penetration. The expanding healthcare infrastructure, higher dermatology awareness, and industrial-scale API production boost the market growth. However, regulatory compliance impacts industrial desoximetasone procurement, requiring suppliers to hold GMP certifications, USDMF/CEP filings, and verified impurity profiles, along with rigorous qualification processes like site audits and stability testing to meet FDA/EMA standards.

Raw Material for Desoximetasone Production

According to the desoximetasone production plant project report, the raw material for desoximetasone production includes 16α-Methyl-4-Pregnene-11β,21-diol-3,20-Dione.

Production Process of Desoximetasone

The extensive desoximetasone production cost report consists of the following major industrial production process:

1. Production via a multi-step microbial fermentation process: The production process of desoximetasone occurs through a multi-step microbial fermentation process starting with the production of 16α-Methyl-4-Pregnene-11β,21-diol-3,20-Dione (16α-Methylcorticosterone). The process takes place in a stainless-steel fermenter using Curvularia lunata on a sterilised nutrient medium (corn steep liquor, glucose, salts), involving inoculation, 24-hour cultivation at 25 °C with stirring (220 rpm) and aeration (1.65 m³/hr). The next step involves the addition of 7.5 g 16α-methyldesoxycorticosterone in ethanol, followed by 28-hour fermentation, filtration, extraction with methyl isobutyl ketone (MIBK), vacuum concentration, and crystallisation from acetone/isopropyl ether, yielding 60% (mp 157-158 °C, purified to 53% via silica gel). In the next step, the intermediate is acetylated with acetic anhydride/pyridine and fluorinated with HF/pyridine at 0 °C to form 16α-methyl-9α-fluoro-Δ4-pregnene-21-ol-3,20-dione-21-acetate. In the following step, the compound undergoes 36-hour fermentation with Curvularia lunata mutant NRRL 2380 for 21-acetate saponification and 11β-hydroxylation, followed by MIBK extraction and silica gel chromatography (chloroform/ethyl acetate 2:1). The resulting crude 16α-Methyl-9α-Fluoro-Δ4-Pregnene-11β,21-Diol-3,20-Dione is finally dehydrogenated via 30-hour fermentation with Bacillus lentus to introduce the Δ¹ double bond, yielding crude desoximetasone after MIBK extraction.

Properties of Desoximetasone

Desoximetasone is a synthetic corticosteroid with the molecular formula C22H29FO4 and a molecular weight of 376.46 g/mol. It appears as a white to almost white crystalline powder. It has a melting point of 213-217 °C, a density of 1.3±0.1 g/cm³, a boiling point around 532.3±50.0 °C at 760 mmHg, and a flash point of 275.7±30.1 °C. It has low water solubility (practically insoluble), moderate solubility in organic solvents like chloroform (specific rotation +109° to +118° at c=1 in CHCl3), and a logP of 2.20, indicating moderate lipophilicity suitable for topical applications. It has a polar surface area (PSA) of 74.6 Ų, a refractive index of 1.574, and negligible vapour pressure (0.0±3.2 mmHg at 25 °C).